PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB…
July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…
Denver, Colorado, July 19, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market matures and moves into its next phase of…
BANGALORE, India, July 17, 2025 /PRNewswire/ -- ACES India Private Limited, a wholly owned subsidiary of Saudi Arabia-based Advanced Communications…
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase…
26 June 2025 - With less than eight months to go until the Milano Cortina 2026, the Organising Committee for the…
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing…
BENGALURU, India, July 3, 2025 /PRNewswire/ -- Pace Digitek Limited (Pace Digitek), an experienced multi-disciplinary solutions provider in the telecom…
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…
SINGAPORE, July 3, 2025 /PRNewswire/ -- Azentio Software ("Azentio"), a leading technology enabler in the banking, financial services, insurance (BFSI),…